Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.
about
Interactions between HLA-G and HLA-E in Physiological and Pathological ConditionsHLA-G Molecules in Autoimmune Diseases and InfectionsSome basic aspects of HLA-G biologyRole of non-classical MHC class I molecules in cancer immunosuppressionBasis for substrate recognition and distinction by matrix metalloproteinasesHLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche.Association of HLA-A and Non-Classical HLA Class I Alleles.HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyStudy of Soluble HLA-G in Congenital Human Cytomegalovirus Infection.Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform Expression.HLA-G dimers in the prolongation of kidney allograft survival.New insights into HLA-G mediated tolerance.HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients.Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.Panduratin A, a possible inhibitor in metastasized A549 cells through inhibition of NF-kappa B translocation and chemoinvasion.Establishment of optimized ELISA system specific for HLA-G in body fluids.HLA-E expression and its clinical relevance in human renal cell carcinoma.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?Hydrogen Sulfide Inhibits High Glucose-Induced sFlt-1 Production via Decreasing ADAM17 Expression in 3T3-L1 Adipocytes.HLA-G expression levels influence the tolerogenic activity of human DC-10.Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.The enzymatic processing of α-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site.Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
P2860
Q21131161-2EAF2836-EE20-457B-8397-1A86493A9643Q26825516-EA3A6192-B34E-4929-A9A5-770F0E0261C4Q26852671-863AB58D-8BCB-4D94-A419-03145265DD51Q26999722-A5334BBC-DE9F-4FE1-8998-FEB718DB930DQ34407655-8AED63FF-D163-4F69-9DFE-398AEBBA86C2Q35229018-41F5D319-E76C-4615-9D20-830C817EC822Q36152723-6C66B8A3-76AE-4DEE-A0CC-871AC420FD38Q36568297-622AAB37-B7D2-478C-BA3F-6E61A7852DB5Q37267886-463297C1-7CDE-4241-AD37-8AD767CCF015Q37677332-0F9FBCC3-A48C-4DD4-A5BA-E8BCC03B87F6Q37700544-84BDFC11-E065-446A-AFA1-18A98BF765E9Q38240763-78F1EE9F-E693-4C19-BFB2-60703F3D78CEQ38789647-6F36847B-0B3D-4C8D-ADBA-C60E9EB436A6Q38999844-FF7A056C-4155-4C30-BAD2-5BE5DB53AC6DQ39120218-6DBB88DA-7CC1-4FC0-B858-AE8D4C23EB74Q39233110-52B9B640-520B-4448-BDEB-370A5D7C7BD8Q39427922-1D5F4A33-BD2A-498B-AB95-E75B96592B53Q40097257-387D96A3-D438-4BC7-8556-400FA88D7BCCQ40979657-40777AD2-731F-42D9-AA04-3E93EEBBA32EQ41465101-2535EF38-10E7-4505-A73C-ECA4ECE87342Q46800781-3EB64E3D-A4AC-4176-9EAA-0631459669DFQ49978939-7BB92F40-3D1A-4AA3-858F-9B1778147886Q57490851-9C4A92D7-F592-4EE5-866B-D467BC9F9870
P2860
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Matrix metalloproteinase-2 (MM ...... surface proteolytic shedding.
@en
Matrix metalloproteinase-2
@nl
type
label
Matrix metalloproteinase-2 (MM ...... surface proteolytic shedding.
@en
Matrix metalloproteinase-2
@nl
prefLabel
Matrix metalloproteinase-2 (MM ...... surface proteolytic shedding.
@en
Matrix metalloproteinase-2
@nl
P2093
P2860
P50
P1476
Matrix metalloproteinase-2 (MM ...... l surface proteolytic shedding
@en
P2093
Antonella Rotola
Enrico Fainardi
Franco Dallocchio
Loredana Melchiorri
Roberta Rizzo
P2860
P2888
P304
P356
10.1007/S11010-013-1708-5
P50
P577
2013-06-05T00:00:00Z